ITRM vs SPRO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SPRO Captures Institutional Edge (2โ1 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Spero Therapeutics, Inc. Common Stock (SPRO) driven by superior Growth & Margin, Momentum & Technical while ITRM counters with relative strength in Options & Structure. Fundamentally, ITRM trades at N/M Forward P/E with -1982.3% operating margin (-100.0% YoY revenue) versus SPRO at N/M Forward P/E and 16.9% operating margin (-95.6% YoY). In options structure, ITRM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SPRO sits in BREAKDOWN (46th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ITRM | SPRO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.8M | $46.2M | Larger Scale | SPRO |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -100.0% | -95.6% | Higher Growth | SPRO |
| Operating Margin (TTM) Profitability | -1982.3% | 16.9% | Higher Margin | SPRO |
| Net Profit Margin Profitability | 0.0% | -71.0% | Higher Margin | ITRM |
| Return on Equity (ROE) Capital Efficiency | -555.7% | -216.4% | Higher ROE | SPRO |
| 52-Week Range Position Momentum | 0% ($0โ$1) | 0% ($1โ$3) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | 1.61ฮฒ ยท 508% Vol | 1.84ฮฒ ยท 60% Vol | Lower Realized Risk | SPRO |
| Unified Institutional Score Composite Signal | 50.5 / 100 (HOLD) | 44.8 / 100 (HOLD) | Higher Composite | ITRM |